Specifically, leukemic cells expressing HSC markers (e.g., CD34+CD38−), as opposed to the bulk of leukemia cells, generated blood cancers in mice after transplantation (with self-renewal inferred by the ability to serially transplant the leukemias from mouse to mouse) (63, 64). The gene discussed is CD38; the disease is leukemia.